Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance.
- NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_assertion description "[We have previously shown that glucose-dependent insulinotropic polypeptide (GIP) analogues that originally have been developed to treat diabetes have neuroprotective effects in the brains of the APPswe/PS1?E9 mouse model of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance.
- NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_assertion evidence source_evidence_literature NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance.
- NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_assertion SIO_000772 23568101 NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance.
- NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_assertion wasDerivedFrom befree-20140225 NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance.
- NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_assertion wasGeneratedBy ECO_0000203 NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP568436.RAXuCOvv9bTpgGc0RVLzYVj4Igeq9grANG2u3ZQkpmwLs130_provenance.